Boehringer Ingelheim develops potential treatment for severe COVID-19 complications
The FINANCIAL -- Boehringer Ingelheim announced the initiation of a Phase 2 clinical trial of BI 764198, an inhibitor of ...
ADVERTISEMENT
Tag: COVID-19 Therapeutics Accelerator
ADVERTISEMENT
Popular Last 24h
-
Justice Department Files Voting Rights Suit Against City of Hazleton, Pennsylvania
-
Crews battle fire at Cleveland Metroparks Zoo’s Rainforest exhibit
-
Quantum Computing, Inc. Announces Private Placement of Common Stock for Proceeds of $100 Million
-
The UK Government has announced a full asset freeze against Blood and Honour.
-
Boston Calling 2025 lineup: Dave Matthews Band, Luke Combs, and Fall Out Boy to headline
-
Ampersand wins £22m five-year contract at London Zoo
-
Meta Will Test Showing EBay Listings On Facebook Marketplace. EBay Stock Jumps.
LATEST POSTS
LATESTINTERVIEWS
ADVERTISEMENT
